Current NDC auxiliary source row compounder:583

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 83155-109
Product Ndc: 83155-109
Product Ndc Digits: 83155109
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Phenylephrine Hydrochloride
Proprietary Name Suffix: [empty]
Nonproprietary Name: Phenylephrine Hydrochloride
Dosage Form Name: INJECTION
Route Name: INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Assure Infusions Inc
Establishment Name: Assure Infusions Inc
Establishment Fei: [empty]
Substance Name: PHENYLEPHRINE HYDROCHLORIDE, (+/-)-
Active Ingredients Info: 40 mg/250 mL
History Active Ingredients Raw: PHENYLEPHRINE HYDROCHLORIDE, (+/-)-
History Active Ingredients Info Raw: 40 mg/250 mL
History Dosage Raw: INJECTION
Dea Schedule: [empty]
Package Ndc Raw: 83155-109-25
Package Ndc: 83155-109-25
Package Ndc Digits: 8315510925
Package Ndc11: 83155010925
Package Description: 250 mL in 1 CONTAINER (83155-109-25)
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:583
Source Row Number: 583
Source Row Hash: 44bb2b5e2b3f2cb18ce590b2e5bfaa236ec0efa85776e70d5aef94fc841292cf
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "83155-109",
    "DEASCHEDULE": "",
    "LABELERNAME": "Assure Infusions Inc",
    "SUBSTANCENAME": "PHENYLEPHRINE HYDROCHLORIDE, (+/-)-",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "83155-109-25",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Phenylephrine Hydrochloride",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "Phenylephrine Hydrochloride",
    "PACKAGEDESCRIPTION": "250 mL in 1 CONTAINER (83155-109-25) ",
    "ACTIVEINGREDIENTSINFO": "40 mg/250 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:583
Source Row Number: 583
Status Scope: package
Lookup Ndc: 83155-109-25
Lookup Ndc Digits: 8315510925
Product Ndc: 83155-109
Product Ndc Digits: 83155109
Package Ndc: 83155-109-25
Package Ndc Digits: 8315510925
Package Ndc11: 83155010925
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 44bb2b5e2b3f2cb18ce590b2e5bfaa236ec0efa85776e70d5aef94fc841292cf
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20